Key result
Tisdale Risk Score predicts QTc prolongation in ICU patients with ~97% sensitivity but low specificity.
Why the study?
A predictive tool to identify ICU patients at high risk of QTc interval prolongation could assist in monitoring and management, but the Tisdale Risk Score's validity in a medical ICU was not established.
Does the Tisdale et al. Risk Score accurately predict QTc interval prolongation in medical ICU patients?
Cohort (n=264)
Does the Tisdale et al. Risk Score accurately predict QTc interval prolongation in medical ICU patients?
Effect estimate: Sensitivity 97% (95% CI 91-99)
The Tisdale Risk Score demonstrates high sensitivity (97%) but low specificity (16%) for predicting QTc prolongation in medical ICU patients, making it useful for identifying at-risk patients but not for reliably ruling out risk.
No takes yet. Share an insight, caveat, or question.
Supports identifying high-risk medical ICU patients for monitoring; leaves open whether score-guided strategies improve outcomes.
Su et al. (2020) conducted a cohort in QTc interval prolongation (n=264). Tisdale et al. Risk Score (TRS) was evaluated on First occurrence of QTc interval prolongation (QTc > 500 ms or increase ≥ 60 ms above baseline) (Sensitivity 97%, 95% CI 91-99). The Tisdale Risk Score demonstrated high sensitivity (97%; 95% CI 91-99%) but low specificity (16%) for predicting QTc interval prolongation in medical ICU patients.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: